Hybio Pharmaceutical, Hybio Health, and BMC Medical Sign Strategic Cooperation Agreement to Build a New Ecosystem for Sleep Health Management
On May 12, HYBIO PHARMACEUTICAL, HYBIO HEALTH, and BMC Medical signed a strategic cooperation agreement. The three parties will engage in comprehensive strategic cooperation in the field of sleep health across multiple dimensions, including scenario application, technology synergy, scientific research collaboration, market synergy, and user reach. The aim is to provide more precise and comprehensive solutions for patients with sleep disorders.
Zeng Shaoqiang, Vice Chairman of HYBIO PHARMACEUTICAL and Executive Director of HYBIO HEALTH, and Zhuang Zhi, Chairman and General Manager of BMC Medical, signed the agreement on behalf of the three parties.
This strategic partnership is a milestone that formally establishes a close and comprehensive strategic relationship among the three parties. Recognizing the alignment of their views on sleep health management solutions and development trends, they will leverage their respective advantages in industry platforms, customer resources, and professional technology. The collaboration will focus on expanding into multiple areas, including product complementarity and scenario, technology synergy and data-driven solutions, and market synergy and user reach. They will actively explore new sleep health management solutions, engage in comprehensive and deep-level exchanges and cooperation, and build a new ecosystem for sleep health management.
Zeng Shaoqiang, Vice Chairman of HYBIO PHARMACEUTICAL and Executive Director of HYBIO HEALTH, stated that BMC Medical is a leading enterprise in China for non-invasive home ventilators and ventilation masks. Its Chinese brand, "Resmart," enjoys a good reputation in the Chinese home respiratory health management market. He hopes that through deepened synergy, the companies will jointly build a sleep health ecosystem covering all scenarios and populations, and promote innovative models for the prevention, treatment, and management of sleep disorders.
Zhuang Zhi, Chairman and General Manager of BMC Medical, congratulated HYBIO PHARMACEUTICAL and HYBIO HEALTH on their achievements and noted that this signing is a new milestone for the strategic cooperation among the three parties. In the future, BMC Medical will continue to leverage its technological innovation advantages and explore more development possibilities with HYBIO PHARMACEUTICAL and HYBIO HEALTH in technology, supply chain, market, and brand.
About HYBIO PHARMACEUTICALFounded in 2003, HYBIO PHARMACEUTICAL has consistently focused on peptide and small nucleic acid drugs. Its products and businesses cover peptide preparations, peptide APIs, oligonucleotide nucleic acids, and CDMO services. The company actively implements a strategy of "combining innovation with generics" and collaborates with over 20 domestic and international research institutions, including the Chinese Center for Disease Control and Prevention, the Institute of Microbiology of the Chinese Academy of Sciences, Shenzhen Institutes of Advanced Technology, and Shenzhen Bay Laboratory. Additionally, the company has partnered with SINOPHARM CNCM on CBD industrial hemp and with Huawei Cloud to advance its "AI-powered Drug Discovery" business.
About HYBIO HEALTH HYBIO HEALTH is dedicated to the scientific research, technological innovation, and industrial development of food-source peptides in the fields of medical foods, health products, functional foods, and specially-formulated foods. Its team members have diverse academic backgrounds, including food science, medicine, biology, pharmacy, nutrition, analytical chemistry, material science, biotechnology, and health management.
About BMC Medical BMC Medical has been a key player in the respiratory health sector for over 20 years. According to a report by Frost & Sullivan in August 2024, the company's BMC brand of home ventilators ranked second in global sales in 2023, covering more than 100 countries and regions worldwide. Its Chinese brand, "Resmart," is the top-selling home ventilator brand in China.